Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2716 Target Snapshot

Histone deacetylase 7 · SINGLE PROTEIN · Homo sapiens

904Compounds
346Assays
11Approved Drugs
961.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q8WUI4. Use UniProt Q8WUI4 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8WUI4 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histone deacetylase 7 as ChEMBL target CHEMBL2716, mapped to UniProt Q8WUI4. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histone deacetylase 7
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2716
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q8WUI4
Histone deacetylase 7
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histone deacetylase 7 is the right protein anchor across sources, using UniProt Q8WUI4 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistone deacetylase 7
UniProt AccessionQ8WUI4
Component TypeProtein
Sequence Length952 aa

Histone deacetylase 7

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histone deacetylase 7, mapped to UniProt Q8WUI4. Sequence length is 952 aa.

Mapped IDQ8WUI4
Review nameHistone deacetylase 7
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

11
Approved
3
Phase III
8
Phase II
4
Phase I
Assay Mix

Activity Type Distribution

IC50881.0
KI57.0
EC501.0
KD22.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3692689 9.0 IC50 1.0 Preclinical
CHEMBL2105763 8.77 Ki 1.7 Clinical
CHEMBL98 8.7 IC50 2.0 Approved
CHEMBL483254 8.64 Ki 2.3 Approved
CHEMBL484073 8.52 IC50 3.0 Preclinical
CHEMBL2105763 8.39 IC50 4.04 Clinical
CHEMBL490018 8.36 IC50 4.4 Preclinical
CHEMBL113537 8.33 Ki 4.7 Preclinical
CHEMBL356066 8.21 IC50 6.11 Clinical
CHEMBL484489 8.2 IC50 6.3 Preclinical
Distribution

pChEMBL Value Distribution

97
5.0
80
5.5
82
6.0
62
6.5
48
7.0
24
7.5
12
8.0
4
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

GIVINOSTAT
CHEMBL1213492
Approved 2024
PANOBINOSTAT
CHEMBL483254
Approved 2015
BELINOSTAT
CHEMBL408513
Approved 2014
VORINOSTAT
CHEMBL98
Approved 2006
Assay Landscape

Assay Landscape

346
Total Assays
416
Tested Compounds
3
Assay Types
Binding — 339 assays, 416 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 233 289 5.9
cell-based format 66 80 5.8
assay format 39 47 5.3
subcellular format 1 0
ADME — 6 assays, 6 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 5 6.4
single protein format 3 1 5.6
Toxicity — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 5.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine